(1R,2R)-(-)-1,2-Diaminocyclohexane

We are (1R,2R)-(-)-1,2-Diaminocyclohexane CAS:20439-47-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  (1R,2R)-(-)-1,2-Diaminocyclohexane
CAS.NO:20439-47-8
Synonyms: 
RR-DIAMINOCYCLOHEXANE
(1R,2R)-(-)-1,2-Cyclohexanediamine
(1R,2R)-Cyclohexane-1,2-diamine
2-Diaminocyclohexane
1R,2R-Diaminocyclohexane
(1R)-(-)-trans-1,2-Diaminocyclohexane
(1R,2R)-(-)-Diaminocyclohexane

Molecular Formula: C6H14N2
Molecular Weight:114.18900

Physical and Chemical Properties:
Density: 0.931
Boiling point: 86-88 ° C 23mm
Melting point: 41-45 ° C
Flash point: 76 ºC
Refractive index: 1.484

Specification:
Appearance:White Crystalline Powder
Purity:≥98%
Moisture Content: Not more than 1.0%
Impurity: Not more than 2.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Oxaliplatin CAS:61825-94-3

(1R,2R)-(-)-1,2-Diaminocyclohexane


Related News: The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.N-(4-Methylphenyl)-3-oxobutanamide CAS:2415-82-9 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.1313900-20-7 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.2740-81-0 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.

Related Products
Product Name
Trioctylamine Cas:1116-76-3 View Details
4-Bromo-2-fluoro-1-(trifluoromethoxy)benzene View Details
6-Chloro-5-fluoroindole View Details
Isopropylphenyl phosphate manufacturer Octyl 4-methoxycinnamate manufacturer 1-Propyl-1H-imidazole manufacturer 5-Bromo-3-nitro-2-pyridinol manufacturer 2,4,6-Triisopropylbenzenesulfonyl chloride manufacturer